InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Powl Brian T., Directeur Commercial. Officer active across 2 companies, notably Fate Therapeutics INC. Cumulatively, 10 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €108k. History available since 27 June 2022. The latest transaction was disclosed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Powl Brian T. is Directeur Commercial and Chief Commercial Officer at Kura Oncology, Inc. and Fate Therapeutics INC. Across 9 filings in total, the recently sampled filings cover the period from 2022-06-29 to 2026-01-27, with 0 in buys and 63712 in sells.